54gene addresses the significant gap in the global genomics market; Nearly 90% of genetic material used in pharmaceutical research is Caucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.

Ingressive Capital

KdT Ventures

Adjuvant Capital

Plexo Capital

Bossanova Investimentos

Cathay Innovation

Diverse Angels

Endeavor Catalyst

Nathalie Gaveau

Y Combinator

V8 Capital Partners

Aera VC

Pioneer Fund

Raba Partnership

Better Ventures

Fifty Years

Bienville Capital

54gene

G4GENE LLC is a Florida-based company that was incorporated on September 17, 2015. It is currently listed as inactive.

G4GENE LLC

COM:54GENE

G4GENE LLC

Filings Not Available